Atara Biotherapeutics, Inc. Financial Ratios — ATRA Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-27.36	-27.79	-55.37	-89.29	-92.43	-81.43	-91.69	-112.39	- -	- -	- -
Return on Assets (%)	- -	-31.27	-35.46	-26.55	-26.85	-49.61	-75.69	-79.2	-65.86	-64.41	-54.06	-101.91	-62.2	50.55
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-89.43
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	100	100	-3.65	83.71	82.44
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,627.91	-432.35	-3,163.15	-60.79	31.45
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,673.85	-441.25	-3,219.48	-64.71	29.69
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,460.58
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,672.05	-359.1	-3,220.7	-66.24	27.09
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,672.28	-359.12	-3,220.88	-66.23	27.07
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,672.28	-359.12	-3,220.88	-66.23	27.07
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.09
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-27.36	-27.79	-55.37	-89.29	-92.43	-81.43	-91.69	-112.39	- -	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	1	16	15	28	72	58	44	10
ST Debt	- -	- -	- -	- -	- -	- -	1	2	2	3	14	12	14	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	14	13	26	58	46	30	9
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.05	-0.05	-0.09	-0.26	-0.21	-0.56	0.27
Net Debt/EBITDA	- -	5.99	0.78	0.41	0.59	0.66	0.26	0.26	0.67	0.32	0.34	0.1	0.32	-0.22
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.05	-0.05	-0.08	-0.26	-0.21	-0.53	0.29
Net Debt/EBIT	- -	5.99	0.78	0.41	0.59	0.65	0.26	0.25	0.65	0.31	0.33	0.09	0.3	-0.24
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-736.89	-51.31	-16.99	10.02
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-748.13	-51.54	-17.04	10.02
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-752.05	-52.22	-18.08	9.46
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	5	4
Common Equity/Total Assets	-86.88	-21.26	97.23	96.96	96.14	81.67	86.48	84.79	78.61	59.73	33.64	-59.96	-89.17	-190.27
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	4.86	2.82	9.13	45.85	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	4.61	2.73	8.29	29.27	-110.48	-55.96	-33.23
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	4.12	2.22	5.45	15.43	27.61	27.42	46.19
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.17	5.41	3.25	10.11	56.62	-58.32	-45.06	-26.95
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.17	5.13	3.15	9.18	36.15	-139.93	-82	-36.89
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.15	4.58	2.55	6.04	19.05	34.97	40.18	51.27
Net Debt to Equity	112.88	468.5	-21.22	-7.54	-18.9	-44.54	-17.91	-25.56	-43.35	-37.94	-73.39	26.04	25.73	22.03
Net Debt/Capital (%)	53.02	82.41	-26.94	-8.15	-23.31	-80.31	-21.78	-32.01	-72.36	-52.57	-88.18	38.45	31.89	23.17
EBITDA	- -	-9	-28	-58	-81	-121	-233	-289	-301	-331	-275	-271	-78	38
EBITDA-CapEx	- -	-9	-28	-59	-84	-141	-269	-294	-305	-342	-279	-272	-79	38
Operating Income (Loss)	- -	-9	-28	-58	-81	-122	-237	-296	-309	-340	-281	-276	-83	36

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.23	33.87	38.22	33.01	26.43	6.01	7.74	7.05	6.04	3.51	3.08	0.36	0.32	0.57
Current Ratio	3.26	33.99	38.92	33.43	26.93	6.23	8.04	7.43	6.31	3.64	3.74	0.72	0.48	0.82
Quick Ratio	3.23	33.87	38.22	33.01	26.43	6.01	7.74	7.05	6.05	3.52	3.59	0.6	0.33	0.65
CFO/Avg Current Liab	- -	-4.22	-7.83	-5.98	-6.19	-4.69	-5.32	-6.14	-3.02	-2.34	-2.93	-1.75	-0.5	-0.68
Common Equity/Total Assets	-86.88	-21.26	97.23	96.96	96.14	81.67	86.48	84.79	78.61	59.73	33.64	-59.96	-89.17	-190.27
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	4.86	2.82	9.13	45.85	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	4.61	2.73	8.29	29.27	-110.48	-55.96	-33.23
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	4.12	2.22	5.45	15.43	27.61	27.42	46.19
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	0.17	5.41	3.25	10.11	56.62	-58.32	-45.06	-26.95
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.17	5.13	3.15	9.18	36.15	-139.93	-82	-36.89
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.15	4.58	2.55	6.04	19.05	34.97	40.18	51.27
CFO/Total Liabilities	- -	-9.49	-565.58	-376.26	-589.75	-219.22	-339.31	-451.73	-143.71	-116.98	-108.27	-72.89	-33.3	-86.73
CFO/CapEx	- -	-1,988.67	-361.48	-128.12	-19.88	-4.32	-5	-41.1	-40.05	-20.84	-64.5	-157.79	-279.34	- -
Altman's Z-Score	-0.52	0.27	107.26	45.81	23.4	5.41	15.06	5.4	4.29	-1.42	-7.14	-22.28	-28.25	-126.88

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.19	3.09	0.23	7.25	88.32
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	20.06	118.29	1,582.3	50.37	4.13
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.57	2.06	3.98
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	231.91	176.87	91.67
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.13	3.22	5.45	4.7
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2,789.17	113.27	66.91	77.69
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,700.94	160.33	18.12
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,350.38	-126.5	-87.54
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	10	11	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	1	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7	10	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	527	752	411	556	1,596	936	1,637	1,445	315	55	78	132
- Cash & Cash Equivalents	4	52	22	24	48	79	61	74	200	106	93	26	25	8
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	1	16	15	28	72	58	44	10
Enterprise Value	-4	-52	423	431	155	390	1,287	692	1,151	1,102	144	61	79	134
Total Capital	-4	-11	103	315	254	178	339	306	477	308	198	-41	-53	-28
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	0.17	5.13	3.15	9.18	36.15	-139.93	-82	-36.89
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.02	0.01	0.03	0.5	0.95	0.55	0.08
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.18	2.26	7.08	0.62	1.11
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.54
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.75
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	133	676	408	541	1,522	845	1,452	1,476	335	54	100	230
Diluted Enterprise Value	-4	-52	111	652	360	461	1,462	786	1,267	1,398	313	86	118	232
EV per Share	- -	- -	536.58	378.72	134.07	317.38	700.36	304.63	345.13	300.51	37.4	14.26	13.54	18.35
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	20	64	9	129	121
TTM EBITDA	- -	-9	-28	-58	-81	-121	-233	-289	-301	-331	-275	-271	-78	38
TTM Operating Income	- -	-9	-28	-58	-81	-122	-237	-296	-309	-340	-281	-276	-83	36
TTM Cash Flow to Firm	- -	-6	-17	-37	-60	-88	-180	-236	-181	-221	-270	-188	-64	-47
TTM Free Cash Flow to Firm	- -	-6	-17	-37	-57	-67	-144	-230	-176	-210	-266	-186	-64	-47

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-8.04	-18.33	-7.16	-8.04	-10.58	-3.68	-8.24	-7.03	-1.26	-0.28	-1.46	-4.52
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.75
Enterprise Value	-4	-52	423	431	155	390	1,287	692	1,151	1,102	144	61	79	134
Low Price	- -	- -	241.5	430	311.25	295	415	259.5	113	295.25	70.75	4.97	6.5	5.01
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.18	2.26	7.08	0.62	1.11
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.54
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.94
Price/Earnings Average	- -	- -	-4.35	-16.97	-6.9	-3.86	-7.4	-4.12	-3.32	-4.34	-3.11	-0.85	-1.13	4.1
Price/Earnings High	- -	- -	-6.31	-29.31	-9.45	-5.75	-10.34	-7.4	-6.8	-6.02	-7.56	-2.16	-3.46	7.27
Price/Earnings Low	- -	- -	-1.72	-7.69	-4.53	-2.95	-3.15	-1.83	-1.09	-3.25	-1.26	-0.08	-0.57	1.92
Price/Book Value	- -	- -	5.11	2.39	1.62	3.13	4.71	3.22	3.54	5.17	2.48	-0.55	-0.8	-3.44
Price/Book Value Average	- -	- -	4.66	3.43	2.16	2.67	5.28	4.56	2.48	5.17	5.27	-2.37	-0.78	-2.03
Price/Book Value High	- -	- -	6.77	5.92	2.96	3.97	7.38	8.2	5.09	7.16	12.82	-6.05	-2.38	-3.6
Price/Book Value Low	- -	- -	1.84	1.55	1.42	2.04	2.25	2.03	0.82	3.87	2.14	-0.21	-0.39	-0.95
Price/Tangible Book Value	- -	- -	5.11	2.39	1.62	3.13	4.71	3.22	3.54	5.17	2.48	-0.55	-0.8	-3.44
Price/Tangible Book Value Average	- -	- -	4.66	3.43	2.16	2.67	5.28	4.56	2.48	5.17	5.27	-2.37	-0.78	-2.03
Price/Tangible Book Value High	- -	- -	6.77	5.92	2.96	3.97	7.38	8.2	5.09	7.16	12.82	-6.05	-2.38	-3.6
Price/Tangible Book Value Low	- -	- -	1.84	1.55	1.42	2.04	2.25	2.03	0.82	3.87	2.14	-0.21	-0.39	-0.95
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	72.58	5.26	6.33	0.77	1.88
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	72.59	11.15	27.26	0.75	1.11
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	100.62	27.16	69.67	2.29	1.97
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.39	4.54	2.46	0.38	0.52
Price/Cash Flow	- -	- -	-8.02	-18.18	-6.8	-6.18	-8.47	-3.59	-8.03	-6.69	-1.24	-0.28	-1.45	-4.45
Price/Cash Flow Average	- -	- -	-7.32	-26.13	-9.09	-5.27	-9.49	-5.08	-5.62	-6.7	-2.62	-1.21	-1.41	-2.63
Price/Cash Flow High	- -	- -	-10.63	-45.14	-12.45	-7.85	-13.27	-9.14	-11.54	-9.28	-6.38	-3.1	-4.3	-4.67
Price/Cash Flow Low	- -	- -	-2.9	-11.84	-5.96	-4.03	-4.05	-2.26	-1.85	-5.02	-1.07	-0.11	-0.71	-1.23
Price/Free Cash Flow Average	- -	- -	-7.34	-26.33	-9.57	-6.86	-11.86	-5.21	-5.77	-7.03	-2.66	-1.22	-1.41	-2.66
Price/Free Cash Flow High	- -	- -	-10.66	-45.5	-13.1	-10.21	-16.58	-9.37	-11.84	-9.75	-6.49	-3.11	-4.32	-4.73
Price/Free Cash Flow Low	- -	- -	-2.9	-11.94	-6.28	-5.24	-5.06	-2.32	-1.9	-5.27	-1.08	-0.11	-0.71	-1.25
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	67.22	10.15	31.14	0.73	0.66
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	94.65	25.21	73.77	1.94	1.16
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	49.4	3.94	6.2	0.44	0.32
EV/EBITDA Average	- -	5.99	-16.31	-18.08	-6.2	-3.28	-7.41	-4.39	-3.19	-4.13	-2.35	-0.98	-1.2	2.11
EV/EBITDA High	- -	5.99	-24.02	-31.54	-8.71	-5.2	-10.46	-8.06	-7.2	-5.81	-5.83	-2.33	-3.19	3.7
EV/EBITDA Low	- -	5.99	-5.98	-7.98	-3.86	-2.35	-3.01	-1.84	-0.64	-3.03	-0.91	-0.2	-0.73	1.02
EV/EBIT Average	- -	5.99	-16.31	-18.07	-6.17	-3.25	-7.3	-4.29	-3.11	-4.02	-2.3	-0.97	-1.13	2.23
EV/EBIT High	- -	5.99	-24.02	-31.52	-8.67	-5.16	-10.3	-7.87	-7.01	-5.65	-5.71	-2.29	-3	3.92
EV/EBIT Low	- -	5.99	-5.98	-7.97	-3.84	-2.33	-2.96	-1.8	-0.62	-2.95	-0.89	-0.19	-0.68	1.08
Last Price	- -	- -	668.75	660.25	355	452.5	868.5	411.75	490.75	394	82	12.82	13.31	18.09
High Price	- -	- -	886.25	1,639	650	575	1,361.25	1,049.25	705	546.25	423.25	141	39.5	18.95
Enterprise Value Average	-4	-52	459	1,056	501	396	1,730	1,268	960	1,367	646	267	94	80
Enterprise Value High	-4	-52	676	1,842	704	628	2,442	2,326	2,166	1,925	1,603	632	250	141
Enterprise Value Low	-4	-52	168	466	312	283	703	531	191	1,005	250	53	57	39

Shares Outstanding	1	1	1	1	1	1	2	2	3	4	4	4	6	7
Diluted Weighted Avg Shares	- -	1	- -	1	1	1	2	2	3	4	4	4	7	13
Basic Weighted Avg Shares	- -	1	- -	1	1	1	2	2	3	4	4	4	7	13
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.43	15.58	2.02	17.22	9.63
EBITDA per Share	- -	-15.74	-141.16	-57.07	-70.36	-100.94	-133.17	-140.63	-101.63	-88.37	-67.37	-64.02	-10.47	3.03
Operating Income per Share	- -	-15.75	-141.19	-57.12	-70.69	-101.74	-135.3	-144.07	-104.45	-90.87	-68.76	-65.16	-11.14	2.86
Basic EPS, GAAP	- -	-16.04	-140.44	-55.92	-68.78	-100.03	-131.64	-141.78	-103.63	-90.78	-55.96	-65.19	-11.41	2.61
Basic EPS from Cont Ops	- -	-16.04	-140.44	-55.92	-68.78	-100.03	-131.64	-141.78	-103.63	-90.78	-55.96	-65.19	-11.41	2.61
Diluted EPS, GAAP	- -	-16.04	-140.44	-55.92	-68.78	-100.03	-131.64	-141.78	-103.63	-90.78	-55.96	-65.19	-11.41	2.57
Diluted EPS from Cont Ops	- -	-16.04	-140.44	-55.92	-68.78	-100.03	-131.64	-141.78	-103.63	-90.78	-55.96	-65.19	-11.41	2.57
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-10.9	-83.38	-36.31	-52.23	-73.25	-102.58	-114.81	-61.09	-58.86	-66.29	-45.56	-9.18	-4.06
Free Cash Flow per Basic Share	- -	-10.91	-83.61	-36.59	-54.86	-90.19	-123.08	-117.6	-62.61	-61.68	-67.32	-45.85	-9.21	-4.06
Cash & Equivalents per Share	5.42	66.5	132.17	281.53	220.93	135.12	168.46	114.03	150.13	101.2	63.28	12.15	7.25	1.16
Book Value per Share	-4.8	-14.19	130.99	276.8	219.24	144.7	184.36	127.97	138.64	76.25	33	-23.31	-16.6	-5.26
Tangible Book Value per Share	-4.8	-14.19	130.99	276.8	219.24	144.7	184.36	127.97	138.64	76.25	33	-23.31	-16.6	-5.26

Atara Biotherapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)